Although greater progress has been made in the treatment of RA in recent years, such as the clinical application of some disease-modifying anti-rheumatic drugs (DMARDs), including methotrexate, leflunomide, and TNF-α inhibitors, the treatment of RA still faces some challenges. Here, TNF is linked to rheumatoid arthritis.